-
41
HEKİMLERİN FARMAKOEKONOMİ BİLGİ DÜZEYİNİN REÇETELEME DAVRANIŞINA ETKİ EDEN FAKTÖRLERLE İLİŞKİSİNİN DEĞERLENDİRİLMESİ
Published 2025-01-01Subjects: Get full text
Article -
42
Cost-utility and cost–benefit analysis of a multi-component intervention (NEXpro) for neck-related symptoms in Swiss office workers
Published 2025-01-01Subjects: Get full text
Article -
43
Health utility value of overactive bladder in Japanese older adults
Published 2025-01-01Subjects: “…health economic evaluation…”
Get full text
Article -
44
Economic analysis of hemodialysis and urgent-start peritoneal dialysis therapies
Published 2025-01-01Subjects: Get full text
Article -
45
Matters arising: cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing–remitting multiple sclerosis: a systematic review
Published 2025-01-01“…Health Economics Review…”
Get full text
Article -
46
Cost-effectiveness of the addition of sintilimab as a first-line therapy for locally advanced or metastatic oesophageal squamous cell carcinoma: a Chinese healthcare system perspec...
Published 2025-01-01“…Health Economics Review…”
Get full text
Article -
47
Overuse of medical imaging and effects of payer-provider integration: quasi-experimental evidence from Finland
Published 2025-01-01“…Health Economics Review…”
Get full text
Article -
48
Risky behaviours and injuries amongst Catalan children with ADHD: does pharmacological treatment improve outcomes?
Published 2025-02-01“…Health Economics Review…”
Get full text
Article -
49
The impact of multidimensional poverty on antenatal care service utilisation in Malawi
Published 2025-01-01“…Health Economics Review…”
Get full text
Article -
50
Does privatization decrease the structural efficiency in the Chinese hospital sector?
Published 2025-01-01“…Health Economics Review…”
Get full text
Article -
51
What does it drive the relationship between cardiovascular disease mortality and economic development? New evidence from Spain
Published 2025-02-01“…Health Economics Review…”
Get full text
Article -
52
QALYs: The Math Doesn’t Work
Published 2023-07-01“…Journal of Health Economics and Outcomes Research…”
Get full text
Article -
53
The Impacts of Breakthrough Drug Classes on Total Healthcare Expenditures
Published 2016-02-01“…Journal of Health Economics and Outcomes Research…”
Get full text
Article -
54
Use of Open Claims vs Closed Claims in Health Outcomes Research
Published 2023-09-01“…Journal of Health Economics and Outcomes Research…”
Get full text
Article -
55
Applying Machine Learning Techniques to Identify Undiagnosed Patients with Exocrine Pancreatic Insufficiency
Published 2019-02-01“…Journal of Health Economics and Outcomes Research…”
Get full text
Article -
56
Comparative Effectiveness of Remestemcel-L-rknd versus Ruxolitinib in Pediatric Patients with Steroid-Refractory Acute Graft-Versus-Host Disease using Simulated Treatment Compariso...
Published 2021-02-01“…Journal of Health Economics and Outcomes Research…”
Get full text
Article -
57
Real-World Treatment Patterns, Survival, and Costs for Ovarian Cancer in Canada: A Retrospective Cohort Study Using Provincial Administrative Data
Published 2021-12-01“…Journal of Health Economics and Outcomes Research…”
Get full text
Article -
58
Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors
Published 2023-12-01“…Journal of Health Economics and Outcomes Research…”
Get full text
Article -
59
Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer
Published 2024-10-01“…Journal of Health Economics and Outcomes Research…”
Get full text
Article -
60
Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany
Published 2013-12-01“…Journal of Health Economics and Outcomes Research…”
Get full text
Article